Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Research & Development (2016 - 2025)

CV Sciences (CVSI) has disclosed Research & Development for 13 consecutive years, with $18000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 28.0% to $18000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122000.0 through Dec 2025, up 3.39% year-over-year, with the annual reading at $122000.0 for FY2025, 3.39% up from the prior year.
  • Research & Development hit $18000.0 in Q4 2025 for CV Sciences, down from $24000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $410000.0 in Q3 2021 to a low of $18000.0 in Q4 2025.
  • Historically, Research & Development has averaged $96250.0 across 5 years, with a median of $38000.0 in 2023.
  • Biggest five-year swings in Research & Development: plummeted 90.93% in 2022 and later soared 169.7% in 2023.
  • Year by year, Research & Development stood at $364000.0 in 2021, then tumbled by 90.93% to $33000.0 in 2022, then skyrocketed by 169.7% to $89000.0 in 2023, then plummeted by 71.91% to $25000.0 in 2024, then fell by 28.0% to $18000.0 in 2025.
  • Business Quant data shows Research & Development for CVSI at $18000.0 in Q4 2025, $24000.0 in Q3 2025, and $50000.0 in Q2 2025.